# Chugai Pharmaceutical

> Chugai Pharmaceutical is a VC fund in Tokyo backing Medical and Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 1
- Last investment: Oct 2020
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.chugai-pharm.co.jp/english/

Chugai Pharmaceutical is a VC fund in Tokyo focused on Medical and Health Care. Chugai Pharmaceutical focuses its business on manufacturing, sales, import, and export of pharmaceuticals. The company's goal is to contribute to the realization of advanced and sustainable patient-centric healthcare as a top innovator in the healthcare industry through innovation.

## Contacts

5 contacts available for Chugai Pharmaceutical. Shizune tracks 4 team members at Chugai Pharmaceutical. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/chugai-pharmaceuticals?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Medical Device | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hirotake Shiraiwa | Group Manager, Research Division | 0 | https://shizune.co/investors/profile/hirotake-shiraiwa |
| Jūzō Ueno | Founder | 0 | https://shizune.co/investors/profile/j%C5%ABz%C5%8D-ueno |
| Osamu Nagayama | CEO | 0 | https://shizune.co/investors/profile/osamu-nagayama |
| William Burns | Director | 0 | https://shizune.co/investors/profile/william-m-burns |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AdipoSeeds | AdipoSeeds, though a novel technology, creates platelets from mesenchymal stem cells without a complex and costly gene transfer. It aims to invent new blood supply system to solve the shortage of platelets in the world, and to create a future where a platelet-related treatment will be cheaply and safely provided. | $56.7M | Seed | Oct 16, 2020 |  |

1 of 1 investments shown.

## Co-investors
- [Dogan](https://shizune.co/investors/profile/dogan-ac72) — VC Fund, 1 deal together
- [Keio Innovation Initiative](https://shizune.co/investors/profile/keio-innovations-initiative) — VC Fund, 1 deal together
- [KSP](https://shizune.co/investors/profile/ksp) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Japan](https://shizune.co/investors/medical-device-investors-japan)
- [Medical Device VC Funds in Japan](https://shizune.co/investors/medical-device-vc-funds-japan)

## FAQ

### What does Chugai Pharmaceutical invest in?

Chugai Pharmaceutical invests primarily in Medical, Health Care and Medical Device startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Chugai Pharmaceutical?

Public channels for Chugai Pharmaceutical include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Chugai Pharmaceutical?

The team at Chugai Pharmaceutical includes Hirotake Shiraiwa (Group Manager, Research Division), Jūzō Ueno (Founder) and Osamu Nagayama (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co